AP

Andrew J. Phillips

CT C4 Therapeutics: 5 patents #2 of 23Top 9%
AB Acerta Pharma B.V.: 1 patents #1 of 21Top 5%
DI Dana-Farber Cancer Institute: 1 patents #63 of 212Top 30%
📍 Guilford, CT: #4 of 62 inventorsTop 7%
🗺 Connecticut: #111 of 3,623 inventorsTop 4%
Overall (2024): #20,048 of 561,600Top 4%
7
Patents 2024

Issued Patents 2024

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
12180225 N/O-linked degrons and degronimers for protein degradation Christopher G. Nasveschuk, James A. Henderson, Yanke Liang, Minsheng He, Martin Duplessis +1 more 2024-12-31
12076405 Heterocyclic degronimers for target protein degradation Christopher G. Nasveschuk, James A. Henderson, Yanke Liang, Mark Fitzgerald, Minsheng He +1 more 2024-09-03
12048747 Substituted piperidine Degronimers for Target Protein degradation Christopher G. Nasveschuk, James A. Henderson, Yanke Liang, Chi-Li Chen, Martin Duplessis +2 more 2024-07-30
12048748 Spirocyclic degronimers for target protein degradation Christopher G. Nasveschuk, James A. Henderson, Yanke Liang, Kiel Lazarski, Ryan E. Michael 2024-07-30
12023385 Tunable endogenous protein degradation with heterobifunctional compounds Dennis Buckley, Georg Winter, Timothy Heffernan, James E. Bradner, Justin Roberts +1 more 2024-07-02
12024520 Processes for the preparation of 4-{8-amino-3-[(2S)-1-(but-2-ynoyl)-pyrrolidin-2-yl]imidazo[1,5-a]-pyrazin-1-yl}N-(pyridin-2-yl)-benzamide Paul Allen Bethel, Lai Chun CHAN, Katie Grace COOPER, Robert John COX, Michael David Golden +15 more 2024-07-02
11992531 C3-carbon linked glutarimide degronimers for target protein degradation Christopher G. Nasveschuk, James A. Henderson, Yanke Liang, Minsheng He, Kiel Lazarski +2 more 2024-05-28